Indication intelligence, analysis and sector perception

Code of Conduct

This code is designed to provide all employees of Regenerative Medicine Investors <RMi> with guidelines for appropriate reporting and conduct. It is a reaffirmation of enduring “Honor the Oath” values and practices.

The central premise of this code is that RMi's reputation for quality reporting, business integrity and independence is our oath and honor code.

Our facts are checked to be accurate, balanced and fairly presented;
Our analyses represent my best independent judgments rather than my preferences;
Our opinions represent my own editorial philosophies;
There are no hidden agendas in any of my analyst and journalistic undertakings;
Acceptance of individual responsibility is to uphold policies governing legal and ethical business practices;
Business integrity is necessary in every reporting decision;
I strive to make sound ethical judgments.

No written policy can definitively set forth the appropriate action for all business situations. This code emphasizes and clarifies a standard of ethical conduct that must govern all of our business dealings and relationships.

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.